Study Highlights Risk of Proteinuria in Patients Receiving Immune Checkpoint Inhibitors Written By Medha Baranwal27 Jan 2025 8:30 PM ISTChina: A recent case-control observational study has raised concerns about developing proteinuria in patients undergoing immune checkpoint inhibitors...
Study Shows Variable Response to Spironolactone in IgA Nephropathy; Safety Confirmed in Higher eGFR Patients Written By Medha Baranwal16 Sept 2024 4:30 AM ISTChina: A recent study published in Kidney and Blood Pressure Research has validated that spironolactone effectively reduces urine protein excretion in...
Superior Renal Protection: Tocilizumab Emerges as Leader in AA amyloidosis Treatment, study finds Written By Medha Baranwal6 Sept 2024 8:30 AM ISTGermany: A recent study has shown the superior efficacy of tocilizumab compared to other bDMARDs in managing systemic inflammation in patients with...
Proteinuria clinically useful predictive marker for developing ocular motor cranial nerve palsy : Study Written By Dr Riya Dave23 Aug 2024 8:00 AM ISTLarge-scale population study researchers have observed a significant association of proteinuria detected by dipstick with the incidence of oculomotor...
Low-Dose Spironolactone found Effective for Proteinuria Reduction in IgA Nephropathy, suggests study Written By Dr. Shravani Dali8 Aug 2024 8:30 PM ISTLow-dose spironolactone found Effective for Proteinuria Reduction in IgA Nephropathy, suggests a study published in the Kidney Blood Press.It's...
Novartis bags USFDA accelerated approval for Fabhalta for reduction of proteinuria in primary IgA nephropathy Written By Ruchika Sharma8 Aug 2024 11:30 AM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta (iptacopan), a...
Iptacopan significantly reduce proteinuria in patients with C3 glomerulopathy, reveals APPEAR-C3G trial Dr. Kamal Kant Kohli1 Jun 2024 7:30 AM ISTNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta (iptacopan) at the late-breaking...
Nephrosclerosis patients without diabetes and low levels of proteinuria may have rapid kidney function decline: Study Written By Medha Baranwal29 May 2024 10:00 AM ISTJapan: A groundbreaking post hoc analysis of the BRIGHTEN study has shed light on the intricate relationship between proteinuria and rapid kidney...
Sparsentan superior to irbesartan in focal segmental glomerulosclerosis patients, reveals DUPLEX trial Written By Dr Kartikeya Kohli22 May 2024 8:30 AM ISTUSA: A groundbreaking clinical trial, known as the DUPLEX trial, has unveiled promising results in treating Focal Segmental Glomerulosclerosis (FSGS),...
Blood Urea Nitrogen, Creatinine and Proteinuria as Novel Biomarkers in Parkinson's Disease: Study Written By Dr. Krishna Shah25 April 2024 6:00 AM ISTParkinson's disease (PD) is a progressive neurodegenerative disorder affecting movement and quality of life in the elderly. The causes of PD remain...
Insulin resistance before diabetes onset may increase risk of albuminuria after diabetes onset: Study Written By Medha Baranwal4 April 2024 9:15 PM ISTUSA: A prospective cohort study has revealed an association between lower insulin sensitivity and albuminuria development, suggesting a role for...
Corticosteroids use reduces proteinuria but fails to delay ESKD in immunoglobulin A nephropathy: Study Written By Medha Baranwal15 March 2024 8:45 PM ISTNorway: In a cohort of Norwegian patients with immunoglobulin A nephropathy (IgAN), a recent retrospective cohort study showed no impact of...
